6-K 1 dp51595_6k.htm FORM 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934


For the month of December, 2014
 
 
Commission File Number: 001-36582

Auris Medical Holding AG
(Exact name of registrant as specified in its charter)

Bahnhofstrasse 21
6300 Zug, Switzerland
(Address of principal executive office)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
X
  
Form 40-F
  


Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
    
No
X


Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
    
No
X
 
 
 
 
 

 
SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

   
Auris Medical Holding AG
  
       
       
     
By:
/s/ Thomas Meyer
  
       
Name:
Thomas Meyer
  
       
Title:
Chief Executive Officer
  

Date: December 3, 2014
 
 
 
 
 
EXHIBIT INDEX


Exhibit Number
Description
99.1
Unaudited Condensed Consolidated Interim Financial Information
   
99.2
Management’s Discussion and Analysis of Financial Condition and Results of Operations
   
99.3
Press Release dated December 3, 2014